CAMERON Associates
Home About Us Client News & Info Upcoming Client Events Contact Us Site Map
Select a Client

For more information please contact:
Kevin McGrath
212.554.5462
kevin@cameronassoc.com

Aastrom Biosciences, Inc. (Nasdaq: ASTM)
is developing patient-specific products for the repair or regeneration of human tissues, utilizing the Company's proprietary adult stem cell technology.

May 12, 2008:
AASTROM REPORTS THIRD QUARTER FISCAL YEAR 2008 FINANCIAL RESULTS
- download word.doc (40 Kb) »
April 17, 2008:
Encouraging Clinical Data Reported From Aastrom's First EU Compassionate Use Cardiac Patients
- download word.doc (40 Kb) »
February 8, 2008:
AASTROM REPORTS SECOND QUARTER FISCAL YEAR 2008 FINANCIAL RESULTS
- download word.doc (40 Kb) »
January 15, 2008:
AASTROM ANNOUNCES FIRST PATIENT TREATMENT WITH AUTOLOGOUS STEM CELL THERAPY FOR HEART FAILURE
- download word.doc (40 Kb) »
December 21, 2007:
Aastrom Biosciences Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule
- download word.doc (40 Kb) »
November 8, 2007:
AASTROM BIOSCIENCES, INC. REPORTS FIRST QUARTER FISCAL YEAR 2008 FINANCIAL RESULTS
- download word.doc (40 Kb) »
October 18, 2007:
AASTROM STEM CELL THERAPY DEMONSTRATES POSITIVE RESULTS IN SEVERE LONG BONE NON-UNION FRACTURE TRIAL
- download word.doc (40 Kb) »
October 16, 2007:
Aastrom Biosciences to Raise $13.5 Million in Registered Direct Offering
- download word.doc (40 Kb) »
October 4, 2007:
AASTROM ANNOUNCES POSITIVE INTERIM RESULTS FROM PHASE I/II STUDY INVOLVING USE OF VASCULAR REPAIR CELLS IN PATIENTS WITH CRITICAL LIMB ISCHEMIA
- download word.doc (40 Kb) »
September 10, 2007:
Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results
- download word.doc (40 Kb) »
June 27, 2007:
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
- download word.doc (40 Kb) »
May 8, 2007:
AASTROM REPORTS THIRD QUARTER FISCAL YEAR 2007 FINANCIAL RESULTS
- download word.doc (40 Kb) »
May 7, 2007:
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
- download word.doc (40 Kb) »
April 30, 2007:
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
- download word.doc (40 Kb) »
February 14, 2007:
AASTROM'S U.S. CLINICAL INVESTIGATOR TO REPORT INTERIM DATA ON LONG BONE FRACTURE REPAIR TRIAL
- download word.doc (40 Kb) »
February 7, 2007:
Aastrom Reports Second Quarter Fiscal Year 2007 Financial Results
- download word.doc (40 Kb) »
February 1, 2007:
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
- download word.doc (40 Kb) »
January 17, 2007:
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
- download word.doc (40 Kb) »
December 14, 2006:
Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
- download word.doc (40 Kb) »
November 30, 2006:
AASTROM BIOSCIENCES TO PRESENT AT BMO CAPITAL MARKETS HEALTHCARE CONFERENCE
- download word.doc (40 Kb) »
November 16, 2006:
STEPHEN G. SUDOVAR ELECTED CHAIRMAN OF AASTROM BIOSCIENCES' BOARD OF DIRECTORS
- download word.doc (40 Kb) »
November 9, 2006:
AASTROM BIOSCIENCES, INC. REPORTS FIRST QUARTER FISCAL YEAR 2007 FINANCIAL RESULTS
- download word.doc (40 Kb) »
November 2, 2006:
Aastrom Biosciences to Present at Rodman & Renshaw 8th Annual Healthcare Conference
- download word.doc (40 Kb) »
 

Quality Investor Relations Since 1976
© 2003 Cameron Associates. All rights reserved.